Literature DB >> 23551034

Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries.

I Garcia-Doval1, S J Rustenbach, R Stern, T N Dam, A D Cohen, C Baker, P I Spuls, L Naldi.   

Abstract

Entities:  

Keywords:  *registries; comparative effectiveness; epidemiology; psoriasis; psoriasis/*drug therapy; research

Mesh：

Year:  2013        PMID： 23551034     DOI： 10.1111/bjd.12344

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  In the Real World: Infections Associated with Biologic and Small Molecule Therapies in Psoriatic Arthritis and Psoriasis.

Authors:  Sarah A R Siegel; Kevin L Winthrop
Journal:  Curr Rheumatol Rep       Date:  2019-06-06       Impact factor: 4.592

2.  Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.

Authors:  K Reich; U Mrowietz; M A Radtke; D Thaci; S J Rustenbach; C Spehr; M Augustin
Journal:  Arch Dermatol Res       Date:  2015-09-10       Impact factor: 3.017

Review 3.  Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis.

Authors:  Zenas Z N Yiu; Lesley S Exton; Zarif Jabbar-Lopez; M Firouz Mohd Mustapa; Eleanor J Samarasekera; A David Burden; Ruth Murphy; Caroline M Owen; Richard Parslew; Vanessa Venning; Darren M Ashcroft; Christopher E M Griffiths; Catherine H Smith; Richard B Warren
Journal:  J Invest Dermatol       Date:  2016-04-13       Impact factor: 8.551

4.  The global state of psoriasis disease epidemiology: a workshop report.

Authors:  C E M Griffiths; J M van der Walt; D M Ashcroft; C Flohr; L Naldi; T Nijsten; M Augustin
Journal:  Br J Dermatol       Date:  2017-05-28       Impact factor: 9.302
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.